Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy

Pulmonary Arterial Hypertension or PAH is a progressive condition for which there is no cure. Even with substantial pharmacologic advances in the modern treatment era, survival still remains unacceptably poor, as reported in large PAH registries. Preclinical studies suggest that the administration of allogeneic CDCs have the potential to reduce …

  • 100 views
  • 25 Mar, 2021
  • 1 location
Telitacicept in Primary APS Patients

syndrome (APS) patients with three positive antiphospholipid antibodies (aPL) and at least one extra-criteria manifestations, including thrombocytopenia, autoimmune hemolytic anemia, aPL associated

thrombosis
lupus
anticoagulant
antiphospholipid antibodies
glycoprotein
  • 3 views
  • 22 Oct, 2021
  • 1 location
HYDROxychloroquine in Syndrome Primary AntiPhospholipid (HYDROSAPL)

)) associated with antiphospholipid antibodies. The rate of term pregnancies has been improved by conventional treatment (aspirin 100 mg / day with low molecular weight heparin (LMWH) in an isocoagulant dose

  • 7 views
  • 12 Mar, 2022
  • 1 location
Hydroxychloroquine for Prevention of Recurrent Miscarriage.

be useful against mechanisms of Unexplained RM. There is no data concerning the benefit of HQ in RM in the presence or absence of antiphospholipid antibodies or any inherited thrombophilia

thrombophilia
anti-phospholipid antibody
antiphospholipid antibodies
heparin
aspirin
  • 420 views
  • 26 Nov, 2021
  • 26 locations
Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study (API-AHAI)

replacement therapy) were not considered. Several biological risk factors have been suggested (depth of anemia, bilirubin level, leukocyte count, antiphospholipid antibodies) but have not been confirmed in

cancer
  • 0 views
  • 04 Oct, 2022
  • 1 location
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

To evaluate the safety and efficacy of zanubrutinib in the treatment of antiphospholipid syndrome with secondary thrombocytopenia in 10 patients.

cyclophosphamide
rituximab
cyclosporine
  • 0 views
  • 09 Jun, 2022
  • 2 locations
Observational Study of the Performance of Cephen Reagents in the Context of Research Into Lupus Anticoagulants

Lupus anticoagulants (are antiphospholipid antibodies (PSA), the screening of which is done by demonstrating prolongation of coagulation times corrected by the intake of phospholipids (PL).

  • 0 views
  • 07 Jan, 2022
  • 1 location
Placental Pathology and Inflammatory Factor Analysis of OAPS

This investigation is on placental pathological changes and inflammatory factors associated with obstetric antiphospholipid syndrome.

Accepts healthy volunteers
  • 0 views
  • 24 May, 2022
  • 1 location
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome (APS)

Antiphospholipid antibody syndrome (APS) is characterized by the presence of antiphospholipid antibodies, which are proteins in the blood that interfere with the body's ability to perform normal

coagulopathy
anticoagulant
arthritis
antiphospholipid antibodies
rheumatoid arthritis
  • 562 views
  • 22 Mar, 2022
  • 1 location
Laboratory and Clinical Data in Antiphospholipid Patients

To constitute a registry of antiphospholipid antibodies positive-patients

antiphospholipid antibodies
  • 0 views
  • 28 Dec, 2021
  • 1 location